204 related articles for article (PubMed ID: 2474815)
21. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
22. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical localization of chromogranin in human hypophyses and pituitary adenomas.
Lloyd RV; Wilson BS; Kovacs K; Ryan N
Arch Pathol Lab Med; 1985 Jun; 109(6):515-7. PubMed ID: 2986572
[TBL] [Abstract][Full Text] [Related]
24. Use of nucleolar organizer regions in the histopathological diagnosis of colorectal epithelial neoplasia.
Chida T; Ajioka Y; Watanabe H
Jpn J Clin Oncol; 1992 Apr; 22(2):73-8. PubMed ID: 1377759
[TBL] [Abstract][Full Text] [Related]
25. Significance of AgNOR counts for distinguishing carcinoma from adenoma and hyperplasia in parathyroid gland.
Kanematsu E; Matsui H; Deguchi T; Yamamoto O; Korematsu M; Kobayashi A; Nezasa SI; Yamamoto N; Takeuchi T; Tanaka T; Kawada Y
Hum Pathol; 1997 Apr; 28(4):421-7. PubMed ID: 9104941
[TBL] [Abstract][Full Text] [Related]
26. Cellular proliferation and/or differentiation can condition modifications in the expression of AgNORs in rat anterior pituitary cells during growth.
Carbajo S; Carvajal JC; Rodríguez J; Carbajo-Pérez E
Histol Histopathol; 1993 Apr; 8(2):317-21. PubMed ID: 8490259
[TBL] [Abstract][Full Text] [Related]
27. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
28. Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts.
Shibuya M; Saito F; Miwa T; Davis RL; Wilson CB; Hoshino T
Acta Neuropathol; 1992; 84(2):178-83. PubMed ID: 1381860
[TBL] [Abstract][Full Text] [Related]
29. [Silver-stained Nucleolar Organizer Regions (AgNOR)].
Derenzini M; Trerè D
Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299
[TBL] [Abstract][Full Text] [Related]
30. Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry.
Giri DD; Nottingham JF; Lawry J; Dundas SA; Underwood JC
J Pathol; 1989 Apr; 157(4):307-13. PubMed ID: 2715879
[TBL] [Abstract][Full Text] [Related]
31. An improved system for quantifying AgNOR and PCNA in canine tumors.
Hung LC; Pong VF; Cheng CR; Wong FI; Chu RM
Anticancer Res; 2000; 20(5A):3273-80. PubMed ID: 11062753
[TBL] [Abstract][Full Text] [Related]
32. Subclinical adenomas of the human pituitary. New light on old problems.
McComb DJ; Ryan N; Horvath E; Kovacs K
Arch Pathol Lab Med; 1983 Sep; 107(9):488-91. PubMed ID: 6309114
[TBL] [Abstract][Full Text] [Related]
33. Fine structural cytology and immunohistochemistry of the non-adenomatous pars distalis of the human pituitary.
Horvath E
Pathol Res Pract; 1988 Sep; 183(5):631-3. PubMed ID: 3070512
[TBL] [Abstract][Full Text] [Related]
34. Pathology of prolactin cell adenomas of the human pituitary.
Horvath E; Kovacs K
Semin Diagn Pathol; 1986 Feb; 3(1):4-17. PubMed ID: 3303229
[TBL] [Abstract][Full Text] [Related]
35. Immunoelectron microscopic evidence of mammosomatotrophs in human adult and fetal adenohypophyses, rat adenohypophyses and human and rat pituitary adenomas.
Losinski NE; Horvath E; Kovacs K; Asa SL
Anat Anz; 1991; 172(1):11-6. PubMed ID: 2031566
[TBL] [Abstract][Full Text] [Related]
36. Pituitary adenomas in old Sprague-Dawley rats: a histologic, ultrastructural, and immunocytochemical study.
McComb DJ; Kovacs K; Beri J; Zak F
J Natl Cancer Inst; 1984 Nov; 73(5):1143-66. PubMed ID: 6092768
[TBL] [Abstract][Full Text] [Related]
37. AgNOR distribution in serous tumours of the ovary.
Mauri FA; Scampini S; Aldovini D; Ferrero S; Barbareschi M; Dalla Palma P
Pathologica; 1990; 82(1081):487-92. PubMed ID: 1706828
[TBL] [Abstract][Full Text] [Related]
38. Comparative study of dma content and interphase nucleolar organizer regions in human pituitary adenomas.
Stefaneanu L; Murray D; Kovacs K; Smyth HS
Endocr Pathol; 1990 Sep; 1(3):177-182. PubMed ID: 32357599
[TBL] [Abstract][Full Text] [Related]
39. Nucleolar organiser regions in colonic dysplasia. A preliminary study.
Sutherland CG; McMeekin W
Histol Histopathol; 1989 Oct; 4(4):457-8. PubMed ID: 2520479
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of double staining of MIB-1 and AgNORs in primary breast carcinoma.
Kidogawa H; Nanashima A; Yano H; Matsumoto M; Yasutake T; Nagayasu T
Anticancer Res; 2005; 25(6B):3957-62. PubMed ID: 16309183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
